Nurse Practitioner, Family · Crown Point, IN
NPI
1427772730
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2100 N Main St
Crown Point, IN, 46307
Phone (547) 546-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
1,929 services
Medicare patients, 2024
305
Average age 76
Drug cost, 2024
$149K
1,745 prescriptions
Company payments, 2025
$30.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Englert was code 99309 (snf e&m), 1,233 times for 212 patients. In total Rachel Englert billed 1,929 services in 8 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 1,233 | 212 | $59.90 | $74K |
| 99308 SNF E&M | Office | 346 | 124 | $44.11 | $15K |
| 99349 Home E&M - New and Established | Office | 110 | 33 | $69.48 | $7,643 |
| 99348 Home E&M - New and Established | Office | 79 | 24 | $46.60 | $3,681 |
| 99309 SNF E&M | Facility | 60 | 27 | $66.79 | $4,008 |
| 99306 SNF E&M | Office | 50 | 50 | $96.74 | $4,837 |
| 99306 SNF E&M | Facility | 19 | 19 | $114.29 | $2,171 |
| 99345 Home E&M - New and Established | Office | 11 | 11 | $127.21 | $1,399 |
By year: 2022 $3,085 for 53 services; 2023 $144K for 2,278 services; 2024 $114K for 1,929 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Englert prescribed most often to Medicare patients was Sertraline Hcl, with 683 prescriptions and refills. In total Rachel Englert wrote 1,745 Medicare prescriptions that cost $149K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sertraline Hcl Generic | 683 | 683 | 109 | $8,167 |
| Galantamine Hbr Generic | 324 | 324 | 56 | $33K |
| Memantine Hcl Generic | 135 | 135 | 28 | $5,693 |
| Lorazepam Generic | 89 | 89 | 27 | $929 |
| Trazodone Hcl Generic | 77 | 77 | 18 | $1,320 |
| Escitalopram Oxalate Generic | 64 | 64 | 18 | $864 |
| Clonazepam Generic | 50 | 50 | Under 11 | $436 |
| Olanzapine Generic | 48 | 48 | 11 | $1,187 |
| Donepezil Hcl Generic | 42 | 42 | Under 11 | $596 |
| Aripiprazole Generic | 39 | 39 | Under 11 | $9,366 |
| Divalproex Sodium Generic | 22 | 22 | Under 11 | $445 |
| Alprazolam Generic | 20 | 20 | Under 11 | $221 |
| Mirtazapine Generic | 20 | 20 | Under 11 | $932 |
| Ingrezza Valbenazine Tosylate | 17 | 17 | Under 11 | $70K |
| Quetiapine Fumarate Generic | 17 | 17 | Under 11 | $412 |
Brand drugs: 36 claims; generic drugs: 1,709 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel Englert $30.18 ($30.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Sun Pharmaceutical Industries Inc. with $30.18.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $30.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.